Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?
Vitamin d as a potential therapy in amyotrophic lateral sclerosis.
Neurofilament ELISA validation.
Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region.
Tropisetron diminishes demyelination and disease severity in an animal model of multiple sclerosis.
White matter disease: Aquaporin-4 antibody-positive patients may not always fulfil the clinical criteria for neuromyelitis optica.
Casein kinases as potential therapeutic targets.
InMS: Chronic insomnia disorder in multiple sclerosis - a Portuguese multicentre study on prevalence, subtypes, associated factors and impact on quality of life.
Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database.
T Cell Epitope Redundancy: Cross-conservation of the TCR face between Pathogens and Self and its Implications for Vaccines and Auto-immunity.
Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes.
Development and validation of an ELISA for quantification of soluble IFN-β receptor: assessment in multiple sclerosis.
Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.
The cost of medication and the cost of treatment are not the same thing for multiple sclerosis.
Thymosin beta 4 up-regulates miR-200a expression and induces differentiation and survival of rat brain progenitor cells.
The EIIIA domain from astrocyte-derived fibronectin mediates proliferation of oligodendrocyte progenitor cells following CNS demyelination.
Deficient Natural Killer Dendritic Cell Responses Underlay the Induction of Theiler's Virus-Induced Autoimmunity.
White and Gray Matter Volume Changes and Correlation with Visual Evoked Potential in Patients with Optic Neuritis: A Voxel-Based Morphometry Study.
Cortisol awakening response is linked to disease course and progression in multiple sclerosis.
Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study.
Web search behavior and information needs of people with multiple sclerosis: focus group study and analysis of online postings.
Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity.
The brain as 'immunoprecipitator' of serum autoantibodies against NMDAR1.
Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.
Pages
« first
‹ previous
…
596
597
598
599
600
601
602
603
604
…
next ›
last »